Dominique Böttcher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dominique Böttcher has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Uwe T. Bornscheuer
Department of Biotechnology and Enzyme Catalysis Institute of Biochemistry Greifswald University Greifswald Germany
9 shared publications - Christina Möller
Institute of Biochemistry, Department of Biotechnology and Enzyme Catalysis University Greifswald Felix-Hausdorff-Straße 4 17487 Greifswald Germany
2 shared publications - Michael Lammers
Department Synthetic and Structural Biochemistry, Institute of Biochemistry, University of Greifswald, Greifswald, Germany
2 shared publications - Niklas Rimkus
Institute of Biochemistry, Department of Biotechnology and Enzyme Catalysis University Greifswald Felix-Hausdorff-Straße 4 17487 Greifswald Germany
2 shared publications - Ole Schmöker
Department of Synthetic and Structural Biochemistry, Institute of Biochemistry, University of Greifswald, Greifswald, Germany
2 shared publications - Abhishek K. Singh
Friedrich Loeffler-Institute for Medical Microbiology-Virology, University Medicine Greifswald, Greifswald, Germany
1 shared publication
Latest Publications
- Open Access
- 12 November 2025
- Published by Wiley in Advanced Science
- Vol. 13 (6) , e17740
A Modular Biosensor Platform for the Detection of Plastic Monomers and the Engineering of Promiscuous Amidases Toward Challenging Substrates
Stable chemical bonds dictate the properties of industrial chemicals and materials. Particularly the persistence of synthetic polymers like polyurethanes (PUs) contributes to the global issues of waste accumulation and environmental pollution. To accelerate the discovery and engineering of plastic‐degrading biocatalysts, a genetically encoded biosensor platform is established that enzymatically converts polyfunctionalized monomers into (aliphatic) aldehydes and allows their robust detection by a bacterial luciferase. In vivo, in vitro, and hybrid applications of the investigated biosensor system facilitate the bioluminescence‐based assessment of the promiscuous esterase, amidase, and urethanase activity of amidase signature family enzymes, circumventing chromatographic analysis. Furthermore, the biosensor platform guides the selection of improved variants in a site‐saturated enzyme library, exhibiting up to 5.5‐fold enhanced activity toward difficult to hydrolyze screening molecules, including N ‐substituted decanamides, a representative polyether dicarbamate, and a commercial polyester‐PU. The latter contain polyols like diethylene glycol, for which biosensor applications are scarce. Hence, this biosensor platform is not only the first to enable the monitoring of amidase and urethanase activity independent of chromogenic/fluorogenic molecules in real‐time. It expands the detection scope of bacterial luciferases toward plastic monomers like polyols, which will aid advancing current recycling strategies for PU waste and beyond.
- 12 November 2025
- Published by Wiley in Advanced Science
- Vol. 13 (6) , e17740
Open AccessA Modular Biosensor Platform for the Detection of Plastic Monomers and the Engineering of Promiscuous Amidases Toward Challenging Substrates
Stable chemical bonds dictate the properties of industrial chemicals and materials. Particularly the persistence of synthetic polymers like polyurethanes (PUs) contributes to the global issues of waste accumulation and environmental pollution. To accelerate the discovery and engineering of plastic‐degrading biocatalysts, a genetically encoded biosensor platform is established that enzymatically converts polyfunctionalized monomers into (aliphatic) aldehydes and allows their robust detection by a bacterial luciferase. In vivo, in vitro, and hybrid applications of the investigated biosensor system facilitate the bioluminescence‐based assessment of the promiscuous esterase, amidase, and urethanase activity of amidase signature family enzymes, circumventing chromatographic analysis. Furthermore, the biosensor platform guides the selection of improved variants in a site‐saturated enzyme library, exhibiting up to 5.5‐fold enhanced activity toward difficult to hydrolyze screening molecules, including N ‐substituted decanamides, a representative polyether dicarbamate, and a commercial polyester‐PU. The latter contain polyols like diethylene glycol, for which biosensor applications are scarce. Hence, this biosensor platform is not only the first to enable the monitoring of amidase and urethanase activity independent of chromogenic/fluorogenic molecules in real‐time. It expands the detection scope of bacterial luciferases toward plastic monomers like polyols, which will aid advancing current recycling strategies for PU waste and beyond.
- Open Access
- 12 March 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (7) , e202500072
Identification and Protein Engineering of Galactosidases for the Conversion of Blood Type B to Blood Type O
The supply of blood products such as red blood cells poses a challenge due to rising demand and declining donor numbers. Careful matching of blood products of different types is required. Only type O of the blood types A, B, AB and O can be received by any patient without transfusion incompatibilities. Therefore, O‐type blood can be considered “universal blood” and is especially needed in emergency situations. In this study, we focused on the conversion of the B antigen by enzymatic deglycosylation to generate the H antigen determining O‐type blood. For this, we characterized several previously unstudied α‐1,3‐galactosidases belonging to the GH110 family. Our findings revealed that the α‐1,3‐galactosidase from Pedobacter panaciterrae (PpaGal) exhibits superior efficiency compared to previously described galactosidases. We further increased the activity of PpaGal by 2.5‐fold using site‐directed mutagenesis. Moreover, we solved two crystal structures of PpaGal, one in the apo‐state and another in complex with d ‐galactose. The combination of our mutagenesis study with the solved crystal structures provides valuable information to guide further optimization of PpaGal or other B antigen converting enzymes paving the way for the easier production of universal blood from B‐type blood.
- 12 March 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (7) , e202500072
Open AccessIdentification and Protein Engineering of Galactosidases for the Conversion of Blood Type B to Blood Type O
The supply of blood products such as red blood cells poses a challenge due to rising demand and declining donor numbers. Careful matching of blood products of different types is required. Only type O of the blood types A, B, AB and O can be received by any patient without transfusion incompatibilities. Therefore, O‐type blood can be considered “universal blood” and is especially needed in emergency situations. In this study, we focused on the conversion of the B antigen by enzymatic deglycosylation to generate the H antigen determining O‐type blood. For this, we characterized several previously unstudied α‐1,3‐galactosidases belonging to the GH110 family. Our findings revealed that the α‐1,3‐galactosidase from Pedobacter panaciterrae (PpaGal) exhibits superior efficiency compared to previously described galactosidases. We further increased the activity of PpaGal by 2.5‐fold using site‐directed mutagenesis. Moreover, we solved two crystal structures of PpaGal, one in the apo‐state and another in complex with d ‐galactose. The combination of our mutagenesis study with the solved crystal structures provides valuable information to guide further optimization of PpaGal or other B antigen converting enzymes paving the way for the easier production of universal blood from B‐type blood.
- Open Access
- 22 February 2025
- Published by Springer Nature in AMB Express
- Vol. 15 (1) , 1-9
Staphylococcal SplA and SplB serine proteases target ubiquitin(-like) specific proteases
Staphylococcus aureus is a Gram-positive opportunistic pathogen that has colonized nearly 30% of the human population and can cause life-threatening infections. S. aureus exports a variety of virulence factors, such as a novel set of extracellular serine protease-like proteins (Spls). Spls are expressed by most clinical isolates of S. aureus, but their pathophysiological substrates and role during the infection are largely unknown. Here we characterized the substrate and cleavage specificity of recombinantly expressed SplA and SplB proteins. We identified a group of ubiquitin or ubiquitin-like modifying enzymes including deubiquitinating enzymes from human as well as from bacterial sources to be so far unknown SplA and SplB substrates. Distinct cleavage sites within these substrates for SplA (YLY↓T, FMY↓N) and SplB (VCD↓S) were identified by mass spectrometry and confirmed by site-directed mutagenesis of the target proteins. Since many cellular immune signaling pathways are tightly regulated by ubiquitination, the specific cleavage of ubiquitin modifying enzymes strongly suggests a specific role of Spls in manipulating immune signaling and in competing with other bacteria.
- 22 February 2025
- Published by Springer Nature in AMB Express
- Vol. 15 (1) , 1-9
Open AccessStaphylococcal SplA and SplB serine proteases target ubiquitin(-like) specific proteases
Staphylococcus aureus is a Gram-positive opportunistic pathogen that has colonized nearly 30% of the human population and can cause life-threatening infections. S. aureus exports a variety of virulence factors, such as a novel set of extracellular serine protease-like proteins (Spls). Spls are expressed by most clinical isolates of S. aureus, but their pathophysiological substrates and role during the infection are largely unknown. Here we characterized the substrate and cleavage specificity of recombinantly expressed SplA and SplB proteins. We identified a group of ubiquitin or ubiquitin-like modifying enzymes including deubiquitinating enzymes from human as well as from bacterial sources to be so far unknown SplA and SplB substrates. Distinct cleavage sites within these substrates for SplA (YLY↓T, FMY↓N) and SplB (VCD↓S) were identified by mass spectrometry and confirmed by site-directed mutagenesis of the target proteins. Since many cellular immune signaling pathways are tightly regulated by ubiquitination, the specific cleavage of ubiquitin modifying enzymes strongly suggests a specific role of Spls in manipulating immune signaling and in competing with other bacteria.
- Open Access
- 16 December 2024
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 108 (1) , 1-9
Improved recombinant expression of soluble cathepsin B and L in Escherichia coli
Cysteine cathepsins such as cathepsin B and L play an important role in numerous diseases like acute pancreatitis or SARS-CoV-2 and therefore have high potential for the development of new therapeutics. To be able to screen for potent and selective inhibitors sufficient amounts of protein are required. Here, we present an easy and efficient protocol for the recombinant expression of soluble and active murine cathepsin B and L. For this, we used the strain E. coli SHuffle® T7 Express which is capable of forming disulfide bridges in the cytoplasm. The enzymes were purified by immobilized nickel ion-affinity chromatography. Using different constructs and media, expression levels were significantly improved and expression yields of 80 ± 2 mg L−1 for procathepsin B, which is 16-fold better than previously reported expression yields for procathepsin B, and 37 ± 2 mg L−1 for procathepsin L, were achieved. After activation with dithiothreitol at slightly acidic pH, in vitro kinetic parameters of both cathepsins were determined using the commonly used synthetic substrates Arg-Arg-AMC or Phe-Arg-AMC. Moreover, to investigate the impact of the short C-terminal propeptide of procathepsin B, it was deleted by site-directed mutagenesis, the shortened target protein was expressed and purified, activated in vitro, and its activity was similar to the variant bearing this C-terminal propeptide. Key points: • Recombinant gene expression of cathepsin B and L in E. coli SHuffle® T7 Express • Soluble cathepsin expression with high expression yields • Investigation of the short C-terminal propeptide of cathepsin B
- 16 December 2024
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 108 (1) , 1-9
Open AccessImproved recombinant expression of soluble cathepsin B and L in Escherichia coli
Cysteine cathepsins such as cathepsin B and L play an important role in numerous diseases like acute pancreatitis or SARS-CoV-2 and therefore have high potential for the development of new therapeutics. To be able to screen for potent and selective inhibitors sufficient amounts of protein are required. Here, we present an easy and efficient protocol for the recombinant expression of soluble and active murine cathepsin B and L. For this, we used the strain E. coli SHuffle® T7 Express which is capable of forming disulfide bridges in the cytoplasm. The enzymes were purified by immobilized nickel ion-affinity chromatography. Using different constructs and media, expression levels were significantly improved and expression yields of 80 ± 2 mg L−1 for procathepsin B, which is 16-fold better than previously reported expression yields for procathepsin B, and 37 ± 2 mg L−1 for procathepsin L, were achieved. After activation with dithiothreitol at slightly acidic pH, in vitro kinetic parameters of both cathepsins were determined using the commonly used synthetic substrates Arg-Arg-AMC or Phe-Arg-AMC. Moreover, to investigate the impact of the short C-terminal propeptide of procathepsin B, it was deleted by site-directed mutagenesis, the shortened target protein was expressed and purified, activated in vitro, and its activity was similar to the variant bearing this C-terminal propeptide. Key points: • Recombinant gene expression of cathepsin B and L in E. coli SHuffle® T7 Express • Soluble cathepsin expression with high expression yields • Investigation of the short C-terminal propeptide of cathepsin B
- Open Access
- 29 November 2021
- Published by Wiley in Engineering in Life Sciences
- Vol. 22 (3-4) , 192-203
Engineering and evaluation of thermostable IsPETase variants for PET degradation
Polyethylene terephthalate (PET) is a mass‐produced petroleum‐based synthetic polymer. Enzymatic PET degradation using, for example, Ideonella sakaiensis PETase (IsPETase) can be a more environmentally friendly and energy‐saving alternative to the chemical recycling of PET. However, IsPETase is a mesophilic enzyme with an optimal reaction temperature lower than the glass transition temperature (Tg) of PET, where the amorphous polymers can be readily accessed for enzymatic breakdown. In this study, we used error‐prone PCR to generate a mutant library based on a thermostable triple mutant (TM) of IsPETase. The library was screened against the commercially available polyester‐polyurethane Impranil DLN W 50 for more thermostable IsPETase variants, yielding four variants with higher melting points. The most promising IsPETaseTMK95N/F201I variant had a 5.0°C higher melting point than IsPETaseTM. Although this variant showed a slightly lower activity on PET at lower incubation temperatures, its increased thermostability makes it a more active PET hydrolase at higher reaction temperatures up to 60°C. Several other variants were compared and combined with selected previously published IsPETase mutants in terms of thermostability and hydrolytic activity against PET nanoparticles and amorphous PET films. Our findings indicate that thermostability is one of the most important characteristics of an effective PET hydrolase.
- 29 November 2021
- Published by Wiley in Engineering in Life Sciences
- Vol. 22 (3-4) , 192-203
Open AccessEngineering and evaluation of thermostable IsPETase variants for PET degradation
Polyethylene terephthalate (PET) is a mass‐produced petroleum‐based synthetic polymer. Enzymatic PET degradation using, for example, Ideonella sakaiensis PETase (IsPETase) can be a more environmentally friendly and energy‐saving alternative to the chemical recycling of PET. However, IsPETase is a mesophilic enzyme with an optimal reaction temperature lower than the glass transition temperature (Tg) of PET, where the amorphous polymers can be readily accessed for enzymatic breakdown. In this study, we used error‐prone PCR to generate a mutant library based on a thermostable triple mutant (TM) of IsPETase. The library was screened against the commercially available polyester‐polyurethane Impranil DLN W 50 for more thermostable IsPETase variants, yielding four variants with higher melting points. The most promising IsPETaseTMK95N/F201I variant had a 5.0°C higher melting point than IsPETaseTM. Although this variant showed a slightly lower activity on PET at lower incubation temperatures, its increased thermostability makes it a more active PET hydrolase at higher reaction temperatures up to 60°C. Several other variants were compared and combined with selected previously published IsPETase mutants in terms of thermostability and hydrolytic activity against PET nanoparticles and amorphous PET films. Our findings indicate that thermostability is one of the most important characteristics of an effective PET hydrolase.
- Open Access
- 15 May 2020
- Published by Wiley in ChemCatChem
- Vol. 12 (16) , 4084-4089
A Biocatalytic Cascade Reaction to Access a Valuable Long‐Chain ω‐Hydroxy Fatty Acid
Environmentally‐friendly processes for the manufacturing of valuable industrial compounds like ω‐hydroxy fatty acids (ω‐OHFAs) are highly desirable. Herein, we present such an approach by establishing a two‐step enzymatic cascade reaction for the production of 2,15,16‐trihydroxy hexadecanoic acid (THA). Starting with the easily accessible natural compound ustilagic acid (UA) that is secreted by the corn smut fungus Ustilago maydis, the recombinantly expressed esterase BS2 from Bacillus subtilis and the commercial β‐glucosidase from almonds were applied yielding 86 % product. Both hydrolases do not require expensive cofactors, making the process economically attractive. Additionally, no harmful solvents are required, so that the product THA can be labelled natural to be used in food and cosmetic products.
- 15 May 2020
- Published by Wiley in ChemCatChem
- Vol. 12 (16) , 4084-4089
Open AccessA Biocatalytic Cascade Reaction to Access a Valuable Long‐Chain ω‐Hydroxy Fatty Acid
Environmentally‐friendly processes for the manufacturing of valuable industrial compounds like ω‐hydroxy fatty acids (ω‐OHFAs) are highly desirable. Herein, we present such an approach by establishing a two‐step enzymatic cascade reaction for the production of 2,15,16‐trihydroxy hexadecanoic acid (THA). Starting with the easily accessible natural compound ustilagic acid (UA) that is secreted by the corn smut fungus Ustilago maydis, the recombinantly expressed esterase BS2 from Bacillus subtilis and the commercial β‐glucosidase from almonds were applied yielding 86 % product. Both hydrolases do not require expensive cofactors, making the process economically attractive. Additionally, no harmful solvents are required, so that the product THA can be labelled natural to be used in food and cosmetic products.
- 1 January 2020
- Published by Elsevier in Process Biochemistry
- Vol. 88, 22-30
A whole-cell process for the production of ε-caprolactone in aqueous media
- 1 January 2020
- Published by Elsevier in Process Biochemistry
- Vol. 88, 22-30
A whole-cell process for the production of ε-caprolactone in aqueous media
- 1 September 2012
- Published by Elsevier in Tetrahedron
- Vol. 68 (37) , 7575-7580
A high-throughput assay method to quantify Baeyer–Villiger monooxygenase activity
- 1 September 2012
- Published by Elsevier in Tetrahedron
- Vol. 68 (37) , 7575-7580
A high-throughput assay method to quantify Baeyer–Villiger monooxygenase activity
- 1 December 2009
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 17 (23) , 7878-7883
Insights into the physiological role of pig liver esterase: Isoenzymes show differences in the demethylation of prenylated proteins
- 1 December 2009
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 17 (23) , 7878-7883
Insights into the physiological role of pig liver esterase: Isoenzymes show differences in the demethylation of prenylated proteins